Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 3, 2002, Pages 301-306

  Antczak, Adam ^a,b   Montuschi, Paolo ^a,b   Kharitonov, Sergei ^a,b   Gorski, Pawel ^a,b   Barnes, Peter J ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

8 isoprostane; Aspirin induced asthma; Cysteinyl leukotrienes; Exhaled breath condensate; Prostaglandin E2

Indexed keywords

8 ISOPROSTANE; ACETYLSALICYLIC ACID; ASPIROL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; ISOPROSTANE; LEUKOTRIENE B4; METHYLPREDNISOLONE; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; BREATH TESTS; CYSTEINE; DINOPROST; DINOPROSTONE; F2-ISOPROSTANES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENE B4; LEUKOTRIENES; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYTOCICS; RESPIRATORY SYSTEM; VASOCONSTRICTOR AGENTS;

EID: 0036683652     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2101021     Document Type: Article

References (47)

1. Aspirin-induced asthma: Advances in pathogenesis and management
2. Intolerance to aspirin: Clinical studies and consideration of its pathogenesis
3. Natural history of aspirin-induced asthma
4. Aspirin-induced asthma
5. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
6. Atopy trait in hypersensitivity to nonsteroidal antiinflammatory drugs
7. Aspirin-induced asthma as a viral disease
8. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes
9. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma
10. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects
11. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics
12. Urinary leukotriene E4 in bronchial asthma
13. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin
14. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma
15. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics
16. Structural organisation and promoter activity of the human ryudocan gene
17. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics
18. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
19. 4 excretion in aspirin-sensitive asthma
20. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans
21. 4 excretion
22. Glucocorticosteroids inhibit leukotriene production
23. Inhibition by salmeterol and beclomethasone of late phase response to segmental antigen challenge in asthmatics
24. 4 is a complete secretagogue in human neutrophils: A kinetic study
25. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients
26. Increased 8-isoprostane as in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers
27. Increased 8-isoprostane as non-invasive bio-marker of oxidative stress in cystic fibrosis
28. Bronchial inhalation tests. I. Measurement of non-allergic bronchial responsiveness
29. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma
30. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients
31. Increased nitrotyrosine in exhaled breath condensate of patients with asthma
32. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge
33. Release of peptide leukotriene into nasal secretions after local instillation of aspirin-sensitive asthmatic patients
34. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics
35. 4 during clinical course of bronchial asthma and the effect of oral prednisolone
36. Effect of oral prednisone on airway inflammatory mediators in atopic asthma
37. Effect of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells
38. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients
39. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics
40. 4 release from activated neutrophils
41. 2-isoprostanes in atopic asthmatics: Evidence for oxidant stress
42. 2-isoprostanes as an index of oxidative stress in vivo
43. Superoxide generation by hypodense eosinophils from patients with asthma
44. Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase
45. Generation of 8-epiprostaglandin F2α by human monocytes: Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2
46. Inhaled glucocorticosteroids decrease hydrogen peroxide in expired air condensate in asthmatic patients
47. 4 activates the NADPH oxidase in eosinophils by a pertussis toxin-sensitive mechanism that is largely independent of arachidonic acid mobilization